We provide evidence supporting that an inhibitor targeting the BMP and TGFβ type I and type II receptors will result in the greatest downregulation of Id1, TAK1, and XIAP and induction of apoptotic cell death of lung cancer cells. This evidence concerns the gene XIAP and lung cancer.